Parks S B, Popovich B W, Press R D
Departments of Molecular & Medical Genetics, Oregon Health Sciences University, Portland, USA.
Am J Clin Pathol. 2001 Mar;115(3):439-47. doi: 10.1309/3H1W-V6NH-N3P9-RHFJ.
We evaluated more than 450 patients with thrombophilia or iron overload for the presence of a factor V Leiden (R506Q), prothrombin G20210A, or HFE C282Y mutation using a standard method (polymerase chain reaction [PCR]-restriction fragment length polymorphism) and a comparative real-time PCR fluorescent resonance energy transfer (FRET) hybridization probe melting curve method. There was 100% concordance between the genotypes ascertained by the 2 methods (at each loci). In addition, phenotypic biochemical laboratory parameters measured on a subset of referred patients correlated with their respective genotypes. In the iron overload cohort, HFE C282Y homozygotes (n = 74) had significantly higher (P < .0001) transferrin saturation levels (74% +/- 25%) than did nonhomozygotes (n = 340; 51.4% +/- 28%), suggesting a genotype-dependent increase in body iron loads. In the thrombophilic cohort, the degree of activated protein C resistance (APCR), measured by a clotting time-based test, was associated significantly with the presence of 0 (n = 255; APCR = 2.59 +/- 0.26), 1 (n = 84; APCR = 1.61 +/- 0.13), or 2 (n = 5; APCR = 1.16 +/- 0.04) copies of the mutant factor V Leiden allele. As the fluorescent genotyping method required no postamplification manipulation, genotypes could be determined more quickly and with minimized risk of handling errors or amplicon contamination. In addition to these practical advantages, the FRET method is diagnostically accurate and clinically predictive of phenotypic, disease-associated manifestations.
我们使用标准方法(聚合酶链反应[PCR]-限制性片段长度多态性)以及一种比较性实时PCR荧光共振能量转移(FRET)杂交探针熔解曲线法,对450多名患有血栓形成倾向或铁过载的患者进行评估,以检测是否存在因子V莱顿(R506Q)、凝血酶原G20210A或HFE C282Y突变。两种方法(在每个位点)确定的基因型之间具有100%的一致性。此外,对一部分转诊患者测量的表型生化实验室参数与其各自的基因型相关。在铁过载队列中,HFE C282Y纯合子(n = 74)的转铁蛋白饱和度水平(74%±25%)显著高于非纯合子(n = 340;51.4%±28%)(P <.0001),表明机体铁负荷存在基因型依赖性增加。在血栓形成倾向队列中,通过基于凝血时间的检测方法测得的活化蛋白C抵抗(APCR)程度与突变型因子V莱顿等位基因0个(n = 255;APCR = 2.59±0.26)、1个(n = 84;APCR = 1.61±0.13)或2个(n = 5;APCR = 1.16±0.04)拷贝的存在显著相关。由于荧光基因分型方法无需扩增后操作,因此可以更快地确定基因型,且处理错误或扩增子污染的风险降至最低。除了这些实际优势外,FRET方法诊断准确,对表型、疾病相关表现具有临床预测性。